| Dr Leticia Oliveros, MD | |
|
2441 W La Palma Ave Ste 100, Anaheim, CA 92801-2658 | |
| (657) 282-6356 | |
| Not Available |
| Full Name | Dr Leticia Oliveros |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 2441 W La Palma Ave Ste 100, Anaheim, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912087156 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 000000A51721 (California) | Primary |
| Entity Name | University Of California Irvine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598790529 PECOS PAC ID: 5395658181 Enrollment ID: O20031107000431 |
News Archive
In operation since recently at the Centre hospitalier de l'Université de Montréal (CHUM), the CyberKnife(R) Robotic Radiosurgery System, is revolutionizing the treatment of both cancerous and non-cancerous tumors anywhere in the body. Used in radiation oncology, the CyberKnife System is the latest word in radiosurgery technology. Designed to destroy tumours using radiation beams, it is the first system of its kind to treat tumors non-invasively to be installed in Canada.
BrainTrust Canada, a community rehabilitation organization dedicated to being a leader in brain injury prevention, is launching a national online contest for youth 13 and older in Canada called Sponsor My Head.
Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new clinical study published online in the German pediatric journal, Klinische Padiatrie, showed that adding Masimo SET pulse oximetry screening to the physical examination of newborns was an effective method to achieve early diagnosis of critical congenital heart disease (CHD).
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has completed enrollment in the first of two dose cohorts in its Phase 1 clinical trial of PV-10 for liver cancer, and that the therapy was very well tolerated by all three subjects treated, with substantial evidence of efficacy.
A group of researchers of the University of Ferrara studied the psychological and psychosomatic distress associated with cancer in the march issue of Psychotherapy and Psychosomatics.
› Verified 4 days ago
| Entity Name | Uc Regents Uci Dept Of Pediatrics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235187311 PECOS PAC ID: 5395649222 Enrollment ID: O20031121000860 |
News Archive
In operation since recently at the Centre hospitalier de l'Université de Montréal (CHUM), the CyberKnife(R) Robotic Radiosurgery System, is revolutionizing the treatment of both cancerous and non-cancerous tumors anywhere in the body. Used in radiation oncology, the CyberKnife System is the latest word in radiosurgery technology. Designed to destroy tumours using radiation beams, it is the first system of its kind to treat tumors non-invasively to be installed in Canada.
BrainTrust Canada, a community rehabilitation organization dedicated to being a leader in brain injury prevention, is launching a national online contest for youth 13 and older in Canada called Sponsor My Head.
Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new clinical study published online in the German pediatric journal, Klinische Padiatrie, showed that adding Masimo SET pulse oximetry screening to the physical examination of newborns was an effective method to achieve early diagnosis of critical congenital heart disease (CHD).
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has completed enrollment in the first of two dose cohorts in its Phase 1 clinical trial of PV-10 for liver cancer, and that the therapy was very well tolerated by all three subjects treated, with substantial evidence of efficacy.
A group of researchers of the University of Ferrara studied the psychological and psychosomatic distress associated with cancer in the march issue of Psychotherapy and Psychosomatics.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Leticia Oliveros, MD 200 S Manchester Ave Ste 300, Orange, CA 92868-3219 Ph: (714) 456-2986 | Dr Leticia Oliveros, MD 2441 W La Palma Ave Ste 100, Anaheim, CA 92801-2658 Ph: (657) 282-6356 |
News Archive
In operation since recently at the Centre hospitalier de l'Université de Montréal (CHUM), the CyberKnife(R) Robotic Radiosurgery System, is revolutionizing the treatment of both cancerous and non-cancerous tumors anywhere in the body. Used in radiation oncology, the CyberKnife System is the latest word in radiosurgery technology. Designed to destroy tumours using radiation beams, it is the first system of its kind to treat tumors non-invasively to be installed in Canada.
BrainTrust Canada, a community rehabilitation organization dedicated to being a leader in brain injury prevention, is launching a national online contest for youth 13 and older in Canada called Sponsor My Head.
Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new clinical study published online in the German pediatric journal, Klinische Padiatrie, showed that adding Masimo SET pulse oximetry screening to the physical examination of newborns was an effective method to achieve early diagnosis of critical congenital heart disease (CHD).
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has completed enrollment in the first of two dose cohorts in its Phase 1 clinical trial of PV-10 for liver cancer, and that the therapy was very well tolerated by all three subjects treated, with substantial evidence of efficacy.
A group of researchers of the University of Ferrara studied the psychological and psychosomatic distress associated with cancer in the march issue of Psychotherapy and Psychosomatics.
› Verified 4 days ago
Ritu Khurana Rawal, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Darren Murtari, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Jennifer Linzmeyer, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 714-279-4567 Fax: 714-278-5908 | |
Geman Cheng, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
David J. Cordes, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Ya-mei T. Yu, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Kirtine Lee Yang, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 500 S Anaheim Hills Rd Ste 110, Anaheim, CA 92807 Phone: 714-282-2229 Fax: 877-794-9299 |